Structure Therapeutics (GPCR) Other financing activities (2022 - 2026)

Quarterly Other financing activities fell 76.28% to $37000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Mar 2026, changed 0.32% year-over-year, with the annual reading at $2.0 million for FY2025, 12.47% up from the prior year.

Structure Therapeutics' Other financing activities history spans 5 years, with the latest figure at $37000.0 for Q1 2026.

  • Other financing activities came in at $37000.0 for Q1 2026, down from $1.2 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $18.5 million in Q4 2023 to a low of $37000.0 in Q1 2026.
  • The 5-year median for Other financing activities is $469000.0 (2023), against an average of $2.0 million.
  • Year-over-year, Other financing activities soared 5750.63% in 2023 and then crashed 97.96% in 2024.
  • Structure Therapeutics' Other financing activities stood at $316000.0 in 2022, then skyrocketed by 5750.63% to $18.5 million in 2023, then tumbled by 93.76% to $1.2 million in 2024, then grew by 8.32% to $1.2 million in 2025, then crashed by 97.04% to $37000.0 in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Other financing activities are $37000.0 (Q1 2026), $1.2 million (Q4 2025), and $462000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Structure Therapeutics 8.43 Bn 8.43 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37,000.00
Mar 31, 2026 37,000.00
Dec 31, 2025 1.25 Mn
Dec 31, 2025 1.25 Mn
Sep 30, 2025 462,000.00
Sep 30, 2025 462,000.00
Mar 31, 2025 156,000.00
Mar 31, 2025 156,000.00
Sep 30, 2024 1.15 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 589,000.00
Jun 30, 2024 589,000.00
Mar 31, 2024 53,000.00
Mar 31, 2024 53,000.00
Dec 31, 2023 18.49 Mn
Dec 31, 2023 18.49 Mn
Jun 30, 2023 476,000.00
Jun 30, 2023 476,000.00
Mar 31, 2023 2.60 Mn
Mar 31, 2023 2.60 Mn
Dec 31, 2022 316,000.00
Dec 31, 2022 316,000.00
Sep 30, 2022 288,000.00
Sep 30, 2022 288,000.00
Jun 30, 2022 461,000.00
Jun 30, 2022 461,000.00
Mar 31, 2022 1.45 Mn
Mar 31, 2022 1.45 Mn